布托啡诺的疏水酯类和醚类在阿片受体处的合成及药理学评价
Synthesis and pharmacological evaluation of hydrophobic esters and ethers of butorphanol at opioid receptors.
作者信息
Fulton Brian S, Knapp Brian I, Bidlack Jean M, Neumeyer John L
机构信息
Alcohol and Drug Abuse Research Center, McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA.
出版信息
Bioorg Med Chem Lett. 2008 Aug 15;18(16):4474-6. doi: 10.1016/j.bmcl.2008.07.054. Epub 2008 Jul 17.
Abstract
We synthesized several hydrophobic esters and ethers of butorphanol and assessed their affinities at opioid receptors in CHO cell membranes. Tested compounds displayed moderate to high affinities to the mu and kappa receptors. The findings accord with previous evidence of a lipophilic binding pocket in the opioid receptors that can be accessed to afford good binding affinity without the need for a phenolic hydrogen-bond donor group. The most potent (K(i)=61 pM at mu and 48 pM at kappa) novel agent was (-)-N-cyclobutylmethylmorphinan-3-yl-14-ol phenoxyacetate (4d).
摘要
我们合成了几种丁丙诺啡的疏水酯和醚，并评估了它们在CHO细胞膜中对阿片受体的亲和力。测试的化合物对μ和κ受体表现出中度至高亲和力。这些发现与先前关于阿片受体中存在亲脂性结合口袋的证据一致，该口袋可以被利用以提供良好的结合亲和力，而无需酚类氢键供体基团。最有效的新型药物（μ受体的K(i)=61 pM，κ受体的K(i)=48 pM）是(-)-N-环丁基甲基吗啡喃-3-基-14-醇苯氧基乙酸酯（4d）。
相似文献
1
Synthesis and pharmacological evaluation of hydrophobic esters and ethers of butorphanol at opioid receptors.布托啡诺的疏水酯类和醚类在阿片受体处的合成及药理学评价
Bioorg Med Chem Lett. 2008 Aug 15;18(16):4474-6. doi: 10.1016/j.bmcl.2008.07.054. Epub 2008 Jul 17.
2
Synthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptors.新型单和双价吗啡烷配体对 κ、μ 和 δ 阿片受体的合成和结合亲和力。
Bioorg Med Chem. 2011 May 1;19(9):2808-16. doi: 10.1016/j.bmc.2011.03.052. Epub 2011 Mar 26.
3
Structure-activity relationships of 3-substituted N-benzhydryl-nortropane analogs as nociceptin receptor ligands for the treatment of cough.3-取代的N-二苯甲基降莨烷类似物作为用于治疗咳嗽的孤啡肽受体配体的构效关系
Bioorg Med Chem Lett. 2008 Dec 15;18(24):6340-3. doi: 10.1016/j.bmcl.2008.10.088. Epub 2008 Nov 1.
4
Probes for narcotic receptor mediated phenomena. 44. Synthesis of an N-substituted 4-hydroxy-5-(3-hydroxyphenyl)morphan with high affinity and selective μ-antagonist activity.阿片受体介导现象的探针。44. 高亲和力和选择性 μ 拮抗剂活性的 N-取代 4-羟基-5-(3-羟苯基)吗啡烷的合成。
Eur J Med Chem. 2012 Apr;50:44-54. doi: 10.1016/j.ejmech.2012.01.025. Epub 2012 Jan 20.
5
Affinity identification of delta-opioid receptors using latex nanoparticles.
Bioorg Med Chem Lett. 2006 Jan 1;16(1):158-61. doi: 10.1016/j.bmcl.2005.09.028. Epub 2005 Oct 10.
6
Design, synthesis, and characterization of 6beta-naltrexol analogs, and their selectivity for in vitro opioid receptor subtypes.6β-纳曲醇类似物的设计、合成与表征及其对体外阿片受体亚型的选择性
Bioorg Med Chem Lett. 2009 May 15;19(10):2811-4. doi: 10.1016/j.bmcl.2009.03.095. Epub 2009 Mar 26.
7
Abolished thermal and mechanical antinociception but retained visceral chemical antinociception induced by butorphanol in mu-opioid receptor knockout mice.布托啡诺在μ-阿片受体基因敲除小鼠中消除了热和机械性抗伤害感受，但保留了内脏化学性抗伤害感受。
Neuropharmacology. 2008 Jun;54(8):1182-8. doi: 10.1016/j.neuropharm.2008.03.008. Epub 2008 Mar 27.
8
Further studies of tyrosine surrogates in opioid receptor peptide ligands.阿片受体肽配体中酪氨酸替代物的进一步研究。
Bioorg Med Chem Lett. 2007 May 1;17(9):2656-60. doi: 10.1016/j.bmcl.2007.01.092. Epub 2007 Feb 2.
9
High-affinity carbamate analogues of morphinan at opioid receptors.吗啡喃在阿片受体处的高亲和力氨基甲酸酯类似物。
Bioorg Med Chem Lett. 2007 Mar 15;17(6):1508-11. doi: 10.1016/j.bmcl.2007.01.013. Epub 2007 Jan 17.
10
Evaluation of a series of N-alkyl benzomorphans in cell lines expressing transfected delta- and mu-opioid receptors.
Biochem Pharmacol. 1995 Sep 7;50(6):851-9. doi: 10.1016/0006-2952(95)02007-y.
引用本文的文献
1
Pharmacological Aspects of Over-the-Counter Opioid Drugs Misuse.非处方阿片类药物滥用的药理学方面。
Molecules. 2020 Aug 27;25(17):3905. doi: 10.3390/molecules25173905.
2
Effect of linker substitution on the binding of butorphan univalent and bivalent ligands to opioid receptors.连接子取代对丁丙诺啡单价和双价配体与阿片受体结合的影响。
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1507-9. doi: 10.1016/j.bmcl.2010.01.101. Epub 2010 Jan 25.
本文引用的文献
1
In vivo characterization of (-)(-)MCL-144 and (+)(-)MCL-193: isomeric, bivalent ligands with mu/kappa agonist properties.(-)(-)MCL-144和(+)(-)MCL-193的体内特性：具有μ/κ激动剂特性的同分异构二价配体。
Neurochem Res. 2008 Oct;33(10):2142-50. doi: 10.1007/s11064-008-9752-3. Epub 2008 Jun 5.
2
Synthesis and pharmacological evaluation of 6,7-indolo/thiazolo-morphinans--further SAR of levorphanol.6,7-吲哚/噻唑并吗啡喃的合成与药理学评价——左啡诺的进一步构效关系研究
J Med Chem. 2007 May 31;50(11):2747-51. doi: 10.1021/jm0701674. Epub 2007 May 9.
3
Pharmacological properties of bivalent ligands containing butorphan linked to nalbuphine, naltrexone, and naloxone at mu, delta, and kappa opioid receptors.在μ、δ和κ阿片受体上，含有与纳布啡、纳曲酮和纳洛酮相连的布托啡诺的二价配体的药理特性。
J Med Chem. 2007 May 3;50(9):2254-8. doi: 10.1021/jm061327z. Epub 2007 Apr 4.
4
High-affinity carbamate analogues of morphinan at opioid receptors.吗啡喃在阿片受体处的高亲和力氨基甲酸酯类似物。
Bioorg Med Chem Lett. 2007 Mar 15;17(6):1508-11. doi: 10.1016/j.bmcl.2007.01.013. Epub 2007 Jan 17.
5
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine.重新定义2,6-亚甲基-3-苯并氮杂䓬的构效关系。4. 环唑辛和乙基酮环唑辛的8-[N-(4'-苯基)-苯乙基]甲酰胺类似物的阿片受体结合特性。
J Med Chem. 2006 Sep 7;49(18):5635-9. doi: 10.1021/jm060278n.
6
Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors.含有μ、δ和κ阿片受体同二聚体和异二聚体药效基团的二价配体的合成及初步体外研究。
J Med Chem. 2006 Jan 12;49(1):256-62. doi: 10.1021/jm050577x.
7
Design and synthesis of novel dimeric morphinan ligands for kappa and micro opioid receptors.新型二聚体吗啡喃类κ和μ阿片受体配体的设计与合成
J Med Chem. 2003 Nov 20;46(24):5162-70. doi: 10.1021/jm030139v.
8
Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy.μ-阿片受体激动剂对恒河猴可卡因及食物维持反应和可卡因辨别力的影响：μ-激动剂效能的作用
J Pharmacol Exp Ther. 2002 Mar;300(3):1111-21. doi: 10.1124/jpet.300.3.1111.
9
Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain management.经鼻丁丙诺啡。其药效学和药代动力学特性以及在急性疼痛管理中的治疗潜力综述。
Drugs. 1995 Jul;50(1):157-75. doi: 10.2165/00003495-199550010-00010.
10
A new concept on the mode of interaction of narcotic analgesics with receptors.
J Med Chem. 1965 Sep;8(5):609-16. doi: 10.1021/jm00329a013.
Zotero 插件